Irinotecan and Carboplatin in Treating Patients With Newly Diagnosed Extensive-Stage Small Cell Lung Cancer

NCT00104793 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: carboplatin
DRUG: irinotecan hydrochloride

Sponsor

Japan Multinational Trial Organization